Adenosine triphosphate disodium ATP 987-65-5

99% up by HPLC

Product categories

New Products

Product Details

Product Information

Product name	Adenosine triphosphate disodium / ATP
Synonyms	Adenosine-5'-triphosphate disodium trihydrate; 5'-ATP-Na2; ADENOSINE-5'-TRIPHOSPHATE DISODIUM SALT HYDR.,CALCIUM FREE; Adenosine-5'-triphosphate disodium salt hydrate,water; disodium adenosine 5'-triphosphate trihydrate;
CAS No.	987-65-5
Molecular Formula	C10H16N5O13P3.3H2O.2Na
Molecular Weight	607.21
Molecular Structure
Quality Standard	99% up by HPLC
Appearance	White to off-white powder

COA of Adenosine triphosphate disodium / ATP

Item	Specification	Results
Appearance	A white to off-white powder	Conforms
Identification	IR	Conforms
PH	2.5-3.5	3.03
Loss on drying	≤ 12.0%	7.72%
Fe+	≤ 0.001%	Conforms
Chloride (Cl)	≤ 0.05%	Conforms
Heavy metals	≤ 10 ppm	Conforms
Assay	≥ 99%	99.2%
Conclusion	The sample conforms to standard

Usage

Function and efficacy:

Adenosine triphosphate disodium is a nucleotide derivative involved in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. When the body needs energy for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Adenosine disodium triphosphate can penetrate the blood-cerebrospinal fluid barrier, improve the stability and reconstruction ability of nerve cell membranous structure, and promote the regrowth of neurites. This product and pentose can synthesize nucleic acid under the action of enzymes in vivo; and with phospholipid cholamine under the action of transcytidase, it can synthesize cephalin and cytidine monophosphate.

Indications:

Adjuvant therapy for progressive muscular atrophy, sequelae of cerebral hemorrhage, cardiac insufficiency, myocardial disease and hepatitis.

Combination efficacy:

Compound injection prepared with coenzyme A is used for hepatitis, nephritis, heart failure, etc.

Other effects:

Rapid supraventricular tachycardia, asthenopia, ophthalmoplegia, retinal hemorrhage, central retinitis, optic neuritis, optic atrophy.